BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23286282)

  • 1. Pathology of central nervous system posttransplant lymphoproliferative disorders: lessons from pediatric autopsies.
    Gheorghe G; Radu O; Milanovich S; Hamilton RL; Jaffe R; Southern JF; Ozolek JA
    Pediatr Dev Pathol; 2013; 16(2):67-73. PubMed ID: 23286282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
    J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant lymphoproliferative disorder of the central nervous system.
    Kempf C; Tinguely M; Rushing EJ
    Pathobiology; 2013; 80(6):310-8. PubMed ID: 24013167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.
    Collins MH; Montone KT; Leahey AM; Hodinka RL; Salhany KE; Belchis DA; Tomaszewski JE
    Pediatrics; 2001 Jun; 107(6):E89. PubMed ID: 11389287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
    Ginat DT; Purakal A; Pytel P
    J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
    Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
    Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant lymphoproliferative disorder: a pictorial review.
    Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
    Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H; Taheri S
    Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of the posttransplant lymphoproliferative disorders: from the past to the present.
    Swerdlow SH
    Semin Diagn Pathol; 1997 Feb; 14(1):2-7. PubMed ID: 9044504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization.
    L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Stephens D; Punnett AS; Barton M; Allen UD
    Am J Transplant; 2019 Oct; 19(10):2764-2774. PubMed ID: 30884098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.
    Buell JF; Gross TG; Hanaway MJ; Trofe J; Roy-Chaudhury P; First MR; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):954-5. PubMed ID: 15848587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
    Twombley K; Pokala H; Ardura MI; Harker-Murray P; Johnson-Welch SF; Weinberg A; Seikaly M
    Pediatr Transplant; 2012 Sep; 16(6):E201-9. PubMed ID: 22646132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiologic Differentiation of Primary CNS Posttransplant Lymphoproliferative Disorder From Brain Metastasis.
    White ML; Zhang Y; Cramer J; Yu F; Bierman PJ; Greiner TC
    AJR Am J Roentgenol; 2020 Jul; 215(1):184-191. PubMed ID: 32348186
    [No Abstract]   [Full Text] [Related]  

  • 15. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients.
    Traum AZ; Rodig NM; Pilichowska ME; Somers MJ
    Pediatr Transplant; 2006 Jun; 10(4):505-12. PubMed ID: 16712612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Cavaliere R; Petroni G; Lopes MB; Schiff D;
    Cancer; 2010 Feb; 116(4):863-70. PubMed ID: 20052713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary central nervous system post-transplantation lymphoproliferative disorder.
    Dierickx D; Tousseyn T; Verhoef G
    Cancer; 2010 Jul; 116(14):3521; author reply 3521-2. PubMed ID: 20564159
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.
    Evens AM; Choquet S; Kroll-Desrosiers AR; Jagadeesh D; Smith SM; Morschhauser F; Leblond V; Roy R; Barton B; Gordon LI; Gandhi MK; Dierickx D; Schiff D; Habermann TM; Trappe R
    Am J Transplant; 2013 Jun; 13(6):1512-22. PubMed ID: 23721553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
    Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
    Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant.
    Bonney DK; Htwe EE; Turner A; Kelsey A; Shabani A; Hughes S; Hughes I; Wynn RF
    Pediatr Blood Cancer; 2012 Mar; 58(3):459-61. PubMed ID: 21584931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.